For the first time ever, a new European Patient Charter for patients who suffer from idiopathic pulmonary…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by
The U.S. Food and Drug Administration (FDA) organized a workshop on pulmonary fibrosis, which took…
Founded in 2000, the Pulmonary Fibrosis Foundation (PFF) is a nonprofit organization dedicated to supporting research on the treatment…
The Pulmonary Fibrosis Foundation (PFF) recently submitted research data about more than 1,100 patients who suffer from pulmonary…
CPF Organizing a Series of Educational Activities for the 2014 Pulmonary Fibrosis Awareness Month
Half of it has already passed, but the 2014 Pulmonary Fibrosis Awareness Month in September continues forward, full…
Pharmaceutical company Boehringer Ingelheim Pharmaceuticals, Inc. is sponsoring the documentary Every Breath Counts: Idiopathic Pulmonary Fibrosis, which will air on…
Cases of idiopathic pulmonary fibrosis (IPF) may be caused by exposure to asbestos, as suggested by a…
The clinical stage specialty pharmaceutical company Pacific Therapeutics announced that is looking for a commercialization partner for the sale…
Plant-based biotechnology company iBio, specializing in developing and manufacturing biological products, was recently granted notices of intention…
An advocacy group associated with the Coalition for Pulmonary Fibrosis (CPF) called The Daughters of PF engaged in a national awareness campaign to…